Sargent Investment Group, LLC Novavax Inc Transaction History

Sargent Investment Group, LLC

  • $483 Million
  • Q2 2024

A detailed history of Sargent Investment Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Sargent Investment Group, LLC holds 30,835 shares of NVAX stock, worth $288,307. This represents 0.08% of its overall portfolio holdings.

Number of Shares
30,835
Previous 19,585 57.44%
Holding current value
$288,307
Previous $93,000 319.35%
% of portfolio
0.08%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$3.89 - $20.97 $43,762 - $235,912
11,250 Added 57.44%
30,835 $390,000
Q1 2024

May 10, 2024
SELL
$3.76 - $6.02 $2,857 - $4,575
-760 Reduced 3.74%
19,585 $93,000
Q4 2023

Feb 05, 2024
SELL
$4.8 - $7.67 $23,520 - $37,583
-4,900 Reduced 19.41%
20,345 $97,000
Q3 2023

Nov 13, 2023
BUY
$6.81 - $9.74 $171,918 - $245,886
25,245 New
25,245 $182,000
Q4 2022

Jan 31, 2023
SELL
$8.86 - $25.04 $12,271 - $34,680
-1,385 Reduced 8.88%
14,205 $146,000
Q3 2022

Oct 26, 2022
SELL
$18.2 - $76.12 $109,855 - $459,460
-6,036 Reduced 27.91%
15,590 $282,000
Q2 2022

Jul 26, 2022
BUY
$36.28 - $75.29 $63,961 - $132,736
1,763 Added 8.88%
21,626 $1.11 Million
Q1 2022

May 06, 2022
SELL
$69.73 - $142.9 $9,553 - $19,577
-137 Reduced 0.69%
19,863 $1.46 Million
Q4 2021

Feb 11, 2022
BUY
$134.56 - $217.97 $44,808 - $72,584
333 Added 1.69%
20,000 $2.86 Million
Q3 2021

Nov 12, 2021
SELL
$177.8 - $270.58 $174,244 - $265,168
-980 Reduced 4.75%
19,667 $4.08 Million
Q2 2021

Aug 05, 2021
SELL
$121.0 - $257.67 $160,567 - $341,928
-1,327 Reduced 6.04%
20,647 $4.38 Million
Q1 2021

May 04, 2021
SELL
$112.98 - $319.93 $173,311 - $490,772
-1,534 Reduced 6.53%
21,974 $3.98 Million
Q4 2020

Feb 10, 2021
SELL
$78.74 - $139.5 $110,078 - $195,021
-1,398 Reduced 5.61%
23,508 $2.62 Million
Q3 2020

Nov 12, 2020
SELL
$79.44 - $178.51 $1.04 Million - $2.35 Million
-13,153 Reduced 34.56%
24,906 $2.7 Million
Q2 2020

Aug 11, 2020
SELL
$13.86 - $83.61 $45,738 - $275,913
-3,300 Reduced 7.98%
38,059 $3.03 Million
Q1 2020

May 12, 2020
BUY
$3.93 - $16.0 $89,997 - $366,400
22,900 Added 124.06%
41,359 $562,000
Q4 2019

Jan 30, 2020
SELL
$3.69 - $5.22 $8,217 - $11,624
-2,227 Reduced 10.77%
18,459 $73,000
Q3 2019

Oct 29, 2019
SELL
$4.02 - $7.84 $40,300 - $78,596
-10,025 Reduced 32.64%
20,686 $104,000
Q2 2019

Aug 12, 2019
BUY
$4.93 - $12.2 $151,405 - $374,674
30,711 New
30,711 $180,000

Others Institutions Holding NVAX

# of Institutions
284
Shares Held
84.8M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $731M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Sargent Investment Group, LLC Portfolio

Follow Sargent Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email